Metoprolol Succinate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Metoprolol Succinate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Metoprolol Succinate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 34 USDMF, 17 CEP/COS, 15 EU WC, 17 NDC API, 26 Listed Suppliers, $ API Reference Price

52 API Suppliers
34 USDMF
17 CEP/COS
15 EU WC
17 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 95 FDA Orange Book, 30 Europe, 27 Australia, 33 Listed Dossiers

185 FDF Dossiers
95 FDA Orange Book
30 Europe
27 Australia
33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 10 DKSH, 3 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 32 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 44 Controlled & Modified Release, 39 Direct Compression, 39 Thickeners and Stabilizers, 36 Solubilizers, 35 Disintegrants & Superdisintegrants, 27 Granulation, 25 Lubricants & Glidants, 22 Film Formers & Plasticizers, 18 Co-Processed Excipients, 17 Topical, 16 Taste Masking, 14 Parenteral, 12 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules

81 Fillers, Diluents & Binders
71 Coating Systems & Additives
44 Controlled & Modified Release
39 Direct Compression
39 Thickeners and Stabilizers
36 Solubilizers
35 Disintegrants & Superdisintegrants
27 Granulation
25 Lubricants & Glidants
22 Film Formers & Plasticizers
18 Co-Processed Excipients
17 Topical
16 Taste Masking
14 Parenteral
12 Chewable & Orodispersible Aids
9 Emulsifying Agents
9 Empty Capsules
8 Rheology Modifiers
5 API Stability Enhancers
5 Coloring Agents
4 Surfactant & Foaming Agents
4 Vegetarian Capsules

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 32 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
32 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Finished Drug Prices

2 US Medicaid Prescriptions
12 Finished Drug Prices

MARKET PLACE

8 APIs, 1 FDF Dossiers

8 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

8 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 48 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8SPIL

filter Patent Number Reset all filters

8 All

01 49504655

02 49700530

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 8Y

filter Expiration Date Reset all filters

8 All

01 82035-07-09

Granules Metoprolol Succinate

Product Main Page

01

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SPIL

METOPROLOL SUCCINATE

Pharmtech & Ingredients

Not Confirmed

SPIL

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?